Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Ocular prognosis in Behçet's disease].

I Cochereau-Massin1, B Wechsler, P Le Hoang

  • 1Service d'Ophtalmologie, Hôpital de la Pitié-Salpêtrière, Paris.

Journal Francais D'Ophtalmologie
|January 1, 1992
PubMed
Summary

Behçet

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dopaminergic mechanisms of dynamical social specialization.

Nature·2026
Same author

[Dry eye and qualitative tear alteration in essential blepharospasm].

Journal francais d'ophtalmologie·2022
Same author

Tear osmolarity, dry eye syndrome, blepharospasm and botulinum neurotoxin.

Journal francais d'ophtalmologie·2021
Same author

[Secondary blepharospasm, analysis and pathophysiology of blepharospasm. French translation of the article].

Journal francais d'ophtalmologie·2021
Same author

[Hemifacial spasm. Etiology and management].

Journal francais d'ophtalmologie·2021
Same author

Secondary blepharospasm, analysis and pathophysiology of blepharospasm.

Journal francais d'ophtalmologie·2020

Area of Science:

  • Ophthalmology
  • Rheumatology
  • Immunology

Context:

  • Behçet's disease is a rare multisystem inflammatory disorder.
  • Ocular involvement is a common and potentially sight-threatening complication.
  • Understanding the long-term ocular prognosis is crucial for patient management.

Purpose:

  • To assess the ocular prognosis of Behçet's disease in a cohort of French patients.
  • To identify factors influencing ocular involvement and its severity.
  • To evaluate the long-term visual outcomes and treatment strategies.

Summary:

  • 31 French patients with ocular Behçet's disease were followed for a mean of 6 years.
  • Ophthalmologic manifestations were the initial presentation in 29% of cases.
  • Severe forms (77%) required systemic therapy (steroids and/or immunosuppressants), while minor forms (23%) stabilized with colchicine.
  • At 6 years, visual acuity remained good in most patients (71% > 8/10), with only a slight increase in severe visual impairment (16% < 1/10).
  • HLA B5, sex, and disease completeness were not predictive of ocular involvement or severity.

Impact:

  • Highlights the importance of multidisciplinary collaboration between ophthalmologists and internists for optimal visual outcomes.
  • Demonstrates that with appropriate management, a good visual prognosis is achievable in the majority of patients with ocular Behçet's disease.
  • Provides valuable long-term data on visual acuity and treatment response in this patient population.

Related Experiment Videos